Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Astrocytoma 8Glioblastoma 5Neuroectodermal Tumors, Primitive 3Glioma 3Recurrence 2Oligodendroglioma 2Neurocytoma 2Lymphoma, Non-Hodgkin 2Brain Neoplasms 2Rhabdoid Tumor 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Multiple Myeloma 1Mesothelioma, Malignant 1Meningioma 1Melanoma 1Lung Neoplasms 1Gliosarcoma 1Ganglioglioma 1Esophageal Neoplasms 1Ependymoma 1Craniopharyngioma 1Carcinoma, Non-Small-Cell Lung 1Adrenocortical Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 53Bevacizumab 33Radiotherapy 27Radiation 12Erlotinib Hydrochloride 12Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 8Irinotecan 6Vorinostat 5Sorafenib 5Sirolimus 5temsirolimus 4Magnetic Resonance Spectroscopy 4Immunoglobulin G 4Disulfides 4Carmustine 4veliparib 3plerixafor 3carmustine, poliferprosan 20 drug combination 3Radiosurgery 3Everolimus 3Dasatinib 3Bortezomib 3vandetanib 2tandutinib 2sargramostim 2poly ICLC 2pembrolizumab 2pazopanib 2ferric pyrophosphate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Gliosarcoma × antineoplaston A10 × Clear all
NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
34 enrolled 6 charts
CNSSarcoma

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡